Stem cells as an emerging paradigm in Stroke 3: enhancing the development of clinical trials

Savitz, S. I. et al. (2014) Stem cells as an emerging paradigm in Stroke 3: enhancing the development of clinical trials. Stroke, 45(2), pp. 634-639. (doi: 10.1161/STROKEAHA.113.003379)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Muir, Professor Keith
Authors: Savitz, S. I., Cramer, S. C., Wechsler, L., Aronowski, J., Boltze, J., Borlongan, C., Case, C., Chase, T., Chopp, M., Carmichael, S. T., Cramer, S. C., Duncan, P., Finklestein, S., Fischkoff, S., Guzman, R., Hess, D. C., Huang, D., Hinson, J., Kautz, S., Kondziolka, D., Mays, R., Misra, V., Mitsias, P., Modo, M., Muir, K., Savitz, S. I., Sinden, J., Snyder, E., Steinberg, G., Vahidy, F., Wechsler, L., Willing, A., Wolf, S., Yankee, E., and Yavagal, D. R.
College/School:College of Medical Veterinary and Life Sciences > School of Psychology & Neuroscience
Journal Name:Stroke
Publisher:American Heart Association
ISSN:0039-2499
ISSN (Online):1524-4628

University Staff: Request a correction | Enlighten Editors: Update this record